GenoBank.io (꧁BioIP꧂)

681 posts

GenoBank.io (꧁BioIP꧂) banner
GenoBank.io (꧁BioIP꧂)

GenoBank.io (꧁BioIP꧂)

@genobank_io

#DeSci OG. Our ꧁BioIP꧂ protocol empowers Families & Individuals to establish Ownership & Control over their DNA 🧬 data. Genomics MCP Server. Techstars '24.

Palo Alto, CA Katılım Ekim 2017
1.6K Takip Edilen1.3K Takipçiler
Story
Story@StoryProtocol·
Programmable confidentiality is here. Confidential Data Rails (CDR) turns encrypted data into onchain building blocks, paving the way for new privacy use-cases on Story and beyond. Technical Paper out now ↓
Story tweet media
English
106
91
397
96.1K
GenoBank.io (꧁BioIP꧂) retweetledi
Story France (꧁ 🇫🇷 ꧂)
Story France (꧁ 🇫🇷 ꧂)@frenchie_story·
Les patients peuvent désormais posséder et monétiser leurs données génomiques. bioip.genobank.app @genobank_io permet aux patientes atteintes du cancer du sein au Mexique de classifier leur ADN, détecter les risques tôt et licencier leurs données pour générer des revenus.
Français
1
6
14
765
GenoBank.io (꧁BioIP꧂) retweetledi
Ritik Raj
Ritik Raj@Ritik23333·
Big news The first Bio patent has landed on Verio Patented BioNFTs™ (US-11984203-B1, US-11915808-B1) by @genobank_io now make it possible to certify ownership of genomic data in VCF files. From DNA → IP, we’re entering a new era of data sovereignty where individuals can truly own, control, share, and even be rewarded for their genetic data. This isn’t just about technology. It’s about reshaping the way humanity thinks about genomics, privacy, and value creation in the age of AI and bioinformatics. By staking on the first BioIP @StoryProtocol, you’re not just earning yield you’re endorsing the legitimacy of this breakthrough patent and supporting ethical, transparent, and compliant data sharing. The future of genomic ownership is here. And it starts on @verio_story @mushy @0xbunny_ @ICat4you @BharatWormie
Ritik Raj tweet mediaRitik Raj tweet media
Verio@verio_story

Introducing the first Bio patent on Verio 🧬 Patented BioNFTs™ (US-11984203-B1, US-11915808-B1) @genobank_io now certify ownership of genomic data in VCF files. From DNA → IP: a new era of data sovereignty, where people can control, share, and be rewarded for their genetics.

English
12
6
39
2.8K
GenoBank.io (꧁BioIP꧂)
GenoBank.io (꧁BioIP꧂)@genobank_io·
🙏 Merci @StoryFrance pour votre soutien exceptionnel ! Grâce à @StoryProtocol, les patients peuvent enfin posséder et monétiser leurs données génomiques 🧬 📍 bioip.genobank.app 🇲🇽🌍 Nos patientes au Mexique et dans le monde peuvent maintenant : ✅ Classifier leur ADN ✅ Détecter les risques précocement ✅ Licencier leurs données L’innovation blockchain au service de la santé mondiale !
Story France (꧁ 🇫🇷 ꧂)@frenchie_story

Les patients peuvent désormais posséder et monétiser leurs données génomiques. bioip.genobank.app @genobank_io permet aux patientes atteintes du cancer du sein au Mexique de classifier leur ADN, détecter les risques tôt et licencier leurs données pour générer des revenus.

Français
0
4
4
234
GenoBank.io (꧁BioIP꧂) retweetledi
Aleeza_Arfan
Aleeza_Arfan@khairun4491·
Live now: bioip.genobank.app patients can own understand & monetize their genomic data. Built on Story @genobank_io empowers breast cancer patients in Mexico to classify DNA detect risks early & license data for revenue. AI-driven clinical trials need massive diverse consented biodata until now patients had zero incentive to share. BioIP fixes this ...genomic data registered on Story’s IP Vault with smart contracts enforcing consent royalties & ownership. Your DNA = your most valuable IP. BioIP makes it a vault: ▸ Consent via smart contracts ▸ Automatic royalties ▸ Ownership from day one Your DNA vault. Your keys. Your royalties. 🧬 #BioIP #Genomics #Web3 @StoryProtocol @0xbunny_ @genobank_io
Aleeza_Arfan tweet media
English
10
2
18
328
GenoBank.io (꧁BioIP꧂)
GenoBank.io (꧁BioIP꧂)@genobank_io·
Thank you @storysylee for highlighting the critical importance of AI-driven clinical trials and the need for proper legal frameworks when agentic researchers interact with families and individuals. @StoryProtocol is pioneering the first L1 blockchain with NFT-based licensing frameworks for datasets, with proven success across partners like @psdnai, @Aria_Protocol, @verio_story, and others. At its core, Decentralized Science (DeSci) is about intellectual property - or as we call it, BioIP. Story Protocol is enabling true ownership and fair compensation for the most valuable, non-fungible & scarce datasets: human genomic & clinical data. Thank you for your leadership and continued support in building the infrastructure for ethical biodata sovereignty. 🫡
GenoBank.io (꧁BioIP꧂) tweet media
S.Y. Lee@storysylee

Genetic code and health data are some of our most unique, most valuable IPs as individuals. Yet traditionally, we had little or no scope to monetize them on our terms. AI-driven clinical trials have suffered as a result. That changes with Story-powered BioIP. Because curing diseases like cancer will remain a pipe dream without rich, IP-safe health data.

English
0
2
4
180
Jason Zhao
Jason Zhao@jasonzhao·
The entire world is one massive clinical trial The answers to our biological questions are contained within What’s needful is the political willpower to aggregate it
Patrick Collison@patrickc

Observing some people close to me with chronic health conditions, it's striking how useful Reddit frequently ends up being. I think a core reason is because trials aren’t run for a lot of things, and Reddit provides a kind of emergent intelligence that sits between that which any single physician can marshal and the full rigor of clinical trials. Why aren’t trials run for a lot of things? Well, they’re of course slow and expensive (median cost of $19M for a pivotal trial in 2015[1]; after adjusting for inflation and other phases, maybe that corresponds to a total of $40M today?). But they’re also hard to fund when the intervention in question lacks IP protection since the ensuing knowledge can’t be monetized. As such, trials for diet, over-the-counter supplements, and lifestyle interventions are under-pursued. To give one prosaic example, lots of people think that magnesium improves sleep, but, as far as I know, no trial has ever been run assessing its ability to improve sleep in non-elderly adults without sleep disorders. So, Reddit — in a pretty unstructured way — makes a limited kind of “compounding knowledge” possible. Best practices can be noticed and can imperfectly start to accumulate. For people with chronic health problems, this is a big deal, and I’ve heard lots of stories between “I found something that made my condition much more manageable” all the way to “I found a permanent cure in a weird comment buried deep in a thread”. (Of course, one also sees this outside of medical conditions. I’ve enjoyed the recommended routine in the BodyWeightFitness subreddit, as a comparable kind of distilled practical wisdom[2].) An interesting and somewhat more formalized example of this approach was recently used for long COVID and published earlier this year[3]. After surveying 3,900 individuals, the paper analyzes patient-reported outcomes for 150 different treatments, yielding the figure reproduced below. There are evidently no silver bullets, but it is striking that, say, about half of people find that antihistamines are helpful. I know a number of people who found the learnings from this study to be impactful in improving their daily quality-of-life. Seeing this paper and the Reddit experience makes me wonder whether the approach could somehow be scaled: is there a kind of observational, self-reported clinical trial that could sit between Reddit and these manual approaches? Should there be a platform that covers all major chronic conditions, administers ongoing surveys, and tracks longitudinal outcomes? I don’t really know what the best way to go about this would be, but it feels to me that there could be something important here. There’s a lot of latent data in patients’ subjective experiences that is not today being properly gathered or analyzed.

English
14
1
59
5.8K
S.Y. Lee
S.Y. Lee@storysylee·
Genetic code and health data are some of our most unique, most valuable IPs as individuals. Yet traditionally, we had little or no scope to monetize them on our terms. AI-driven clinical trials have suffered as a result. That changes with Story-powered BioIP. Because curing diseases like cancer will remain a pipe dream without rich, IP-safe health data.
Story@StoryProtocol

Live now: patients can own, understand, and monetize their genomic data. bioip.genobank.app Built on Story, @genobank_io enables breast cancer patients in Mexico to classify their DNA, detect risks early, and license their data for revenue. Global, patient-owned medicine.

English
44
14
135
7.1K
GenoBank.io (꧁BioIP꧂) retweetledi
weird34.ip | ꧁The Bakery DAO꧂ ꧁IP꧂
Your Biosample—>your ꧁BioIP꧂ So, what is GenoBank ? - A Web3 platform that gives people ownership and control over their genetic / genomic data. - Genetic/biosamples are tokenized as BioNFTs™, which represent the data plus all permissions, licensing, and usage tracking. @genobank_io @StoryProtocol
weird34.ip | ꧁The Bakery DAO꧂ ꧁IP꧂ tweet media
Story@StoryProtocol

Live now: patients can own, understand, and monetize their genomic data. bioip.genobank.app Built on Story, @genobank_io enables breast cancer patients in Mexico to classify their DNA, detect risks early, and license their data for revenue. Global, patient-owned medicine.

English
1
1
9
456
GenoBank.io (꧁BioIP꧂)
GenoBank.io (꧁BioIP꧂)@genobank_io·
Thank you @StoryProtocol for an incredible partnership! Together, we’re pioneering Decentralized Digital Biobanking - the foundation for truly ethical DeSci. Every patient deserves fundamental rights: 🧬 Own and control their most valuable biometric data - not surrender it in fine print to centralized entities. 🤖 AI-powered precision medicine co-pilot to navigate healthcare with insights that empower patients. 🌐 Freedom to share biodata and longitudinal clinical history with trusted doctors and researchers worldwide 💰 License and monetize their genetic contributions to research through programmable IP agreements with Researchers and Big Pharma. But it all starts with one revolutionary step: asserting your BioIP on Story Protocol and creating that first Programmable IP License (PIL) for your biological datasets. This is “Decentralized Programmable Licensing for Biological Datasets” BioIP.genobank.app
Story@StoryProtocol

Live now: patients can own, understand, and monetize their genomic data. bioip.genobank.app Built on Story, @genobank_io enables breast cancer patients in Mexico to classify their DNA, detect risks early, and license their data for revenue. Global, patient-owned medicine.

English
3
3
29
935
GenoBank.io (꧁BioIP꧂)
GenoBank.io (꧁BioIP꧂)@genobank_io·
Thank you for the shout out! Personal genomics 🧬 data vaults should be a human right for individuals. No corporation or institution should take pride in legally owning their users’ DNA raw datasets. GenoBank.io & @StoryProtocol are bridging human dignity and research utility for the entire human genomics industry.
GenoBank.io (꧁BioIP꧂) tweet media
English
0
0
1
20
oggy
oggy@oggy_og3·
From Poseidon’s AI training sets to Aria’s song masters to Genobank’s genomes IP Vault powers secure, conditional access for the most valuable digital assets. Built on Story’s Layer 1, it’s confidential, programmable and ready for the future of IP. @StoryProtocol
English
3
1
15
230